Metraipolis › archive › dc_65cbe39ecc8d
Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement — Europe PMC PMID:42344690
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42344690
- DOI
- 10.3389/fonc.2026.1679620
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T15:31:33.291Z
- SHA-256 of the archived text
cdc073492fda8146969c49b2b7afedba1ca0eaf79aebe4d30b6f458a0b847e8e- Stable URL of this page
https://metraipolis.com/documento/dc_65cbe39ecc8d
How to cite
Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement — Europe PMC PMID:42344690 — Europe PMC (en), https://europepmc.org/article/MED/42344690 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_65cbe39ecc8d (Metraipolis archive dc_65cbe39ecc8d, sha256 cdc073492fda8146969c49b2b7afedba1ca0eaf79aebe4d30b6f458a0b847e8e)
BibTeX
@misc{dc65cbe39ecc8d,
title = {Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement — Europe PMC PMID:42344690},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42344690},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_65cbe39ecc8d; sha256 cdc073492fda8146969c49b2b7afedba1ca0eaf79aebe4d30b6f458a0b847e8e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42344690. Agents can read the archived copy with the MCP tool read_document.